Related Experiment Video
Updated: Jul 16, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2
1Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA; Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.
Interferons and their stimulated genes are key to fighting viruses. A new study reveals phospholipid scramblase 1 (PLSCR1) is an interferon-stimulated gene that blocks SARS-CoV-2 cell entry.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Interferons (IFNs) and interferon-stimulated genes (ISGs) are crucial components of the innate immune system.
- These molecules play a vital role in host defense against viral infections.
Purpose of the Study:
- To identify novel interferon-stimulated genes (ISGs) involved in restricting SARS-CoV-2 infection.
- To investigate the mechanism by which PLSCR1 inhibits SARS-CoV-2.
Main Methods:
- Utilized molecular biology techniques to identify and characterize ISGs.
- Investigated the role of PLSCR1 in SARS-CoV-2 infection and virus-cell fusion.
Main Results:
- Identified phospholipid scramblase 1 (PLSCR1) as a novel ISG.
- Demonstrated that PLSCR1 restricts SARS-CoV-2 infection.
- Showed that PLSCR1 functions by blocking virus-cell fusion.
Conclusions:
- PLSCR1 is a newly discovered ISG with antiviral properties against SARS-CoV-2.
- PLSCR1 represents a potential therapeutic target for managing SARS-CoV-2 infections by inhibiting viral entry.
More Related Videos
09:26Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
Related Concept Videos
The Antiviral System of Bacteria and Archaea: CRISPR
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Single Nucleotide Polymorphisms-SNPs
Leaky Scanning